Sophia Antipolis, 15 May 2014. CARDIOSTIM-EHRA EUROPACE 2014 will take place from 18-21 June 2014 in the Nice Acropolis Convention Centre in Nice, France. This year marks the first time Cardiostim and EHRA have collaborated to bring the scientific aspects of their respective congresses together, to create one congress that allows the most eminent specialists in the fields of cardiac electrophysiology and cardiac techniques to gather in one place to deliver, discuss and debate cutting-edge research and training.
This historic first joint congress will include 190 research and training sessions that will be attended by more than 5,500 delegates from 126 countries, for an unequalled scientific program that focuses on electrophysiology and device therapies.
The core of the congress is training and original research on cardiac rhythm disorders that looks at all aspects of care, both diagnostical and therapeutical, and includes the multidisciplinary scientific fields involving cardiac electrophysiology.
“A lot of important research representing every area in the field will be presented at the congress,” said Cecilia Linde, EUROPACE Program Chairperson.
“Much of the discussion and debate will be on topics that are, or soon will be, in the news. Sudden death in sports; discussions about defibrillators in public places; and how early detection of atrial fibrillation may reduce strokes, are just a few of the studies that will be of interest to journalists attending the event.
“Recently it has been demonstrated that remote monitoring of devices may reduce mortality,” said Professor Linde. “This will require set up of workplaces to work in different ways than up front visits to modify heart failure management and prevent future hospitalisations which will be discussed at Cardiostim EHRA EUROPACE. A really hot topic is lead less pacing. Subcutaneous ICDs are increasingly used and do not require venous lead placement. So the field of devices is rapidly developing, and with approaches that are less invasive for the patients.”
Nearly 1,150 abstracts were received for the congress representing all areas of research. Sessions will be included on invasive and non-invasive electrophysiology, catheter ablation, leadless devices, stimulation, new biomarkers and emerging cardiovascular technologies that will help provide the answers to atrial and ventricular fibrillation, heart failure and other rhythm problems.
In addition, information on the trial phases of revolutionary technical advances that were presented at earlier conferences will be discussed, including pacemakers and miniature defibrillators, new catheters with a navigation system based on the magnetic triangulation principle and how genetic factors influence atrial and ventricular fibrillation, heart failure and other rhythm pathologies.
Many of the topics are timely and of interest to the general public. As the world prepares for the World Cup in Brazil, cardiologists at the congress will discuss studies on the sudden death in athletes. And one researcher challenges the idea that all primary preventive Implantable Cardioverter Defibrillators ICDs after myocardial infarction must really be exchanged.
This new collaboration between the leading groups on cardiac rhythm disorders goes a long way towards answering the calls for an annual European congress on cardiac electrophysiology. CARDIOSTIM-EHRA EUROPACE will take place every even year and EHRA EUROPACE-CARDIOSTIM will take place every odd year.
Our mission: To reduce the burden of cardiovascular disease.